The navigation below allows you to jump to any table or figure within the SEER Cancer Statistics Review.

  1. First select the CSR Section, then a Table/Figure from that section.
  2. Use the Submit button to view the table or figure. You will have options to download a printer-friendly version (PDF) or the data table (CSV) as well.

To learn more about the Cancer Statistics Review and the statistics presented in this report, refer to the About the CSR (PDF, 528 KB) and Technical Notes (PDF, 794 KB) pages.


Download and Print: Download Printer-friendly PDF Download data


Table 28.13

Age-Specific Ratesa and Deaths for the Top 5 Cancer Sitesb by Single Year of Age at Death
U.S. Mortalityc 2013-2017

Age at Death Primary Site Rate Number of Deaths
Age <1 All Sites 1.5 293
Leukemia 0.5 102
Acute Lymphocytic Leukemia 0.1 19
Brain and ONSd 0.4 70
Other Endocrine 0.2 31
Soft Tissue 0.1 22
Kidney and Renal Pelvis - -
Age 1 All Sites 1.9 383
Leukemia 0.7 140
Acute Lymphocytic Leukemia 0.3 54
Brain and ONSd 0.4 85
Other Endocrine 0.2 40
Liver & IBDd 0.1 27
Soft Tissue 0.1 25
Age 2 All Sites 2.1 412
Leukemia 0.8 168
Acute Lymphocytic Leukemia 0.3 54
Brain and ONSd 0.4 81
Other Endocrine 0.3 60
Soft Tissue 0.1 29
Liver & IBDd 0.1 23
Age 3 All Sites 2.3 464
Leukemia 0.6 125
Acute Lymphocytic Leukemia 0.2 37
Brain and ONSd 0.6 117
Other Endocrine 0.4 86
Soft Tissue 0.2 36
Liver & IBDd 0.1 20
Age 4 All Sites 2.2 446
Brain and ONSd 0.8 167
Leukemia 0.5 97
Acute Lymphocytic Leukemia 0.2 38
Other Endocrine 0.3 65
Soft Tissue 0.2 38
Kidney and Renal Pelvis 0.1 23
Age 5 All Sites 2.3 474
Brain and ONSd 1.0 210
Leukemia 0.4 88
Acute Lymphocytic Leukemia 0.2 38
Other Endocrine 0.3 66
Soft Tissue 0.2 38
Liver & IBDd 0.1 19
Age 6 All Sites 2.2 438
Brain and ONSd 1.1 217
Leukemia 0.4 83
Acute Lymphocytic Leukemia 0.2 42
Other Endocrine 0.3 54
Soft Tissue 0.1 27
Kidney and Renal Pelvis - -
Age 7 All Sites 2.1 422
Brain and ONSd 0.9 193
Leukemia 0.4 81
Acute Lymphocytic Leukemia 0.2 44
Other Endocrine 0.2 48
Soft Tissue 0.1 30
Bones and Joints 0.1 17
Age 8 All Sites 2.1 424
Brain and ONSd 0.8 165
Leukemia 0.5 105
Acute Lymphocytic Leukemia 0.3 52
Other Endocrine 0.2 39
Soft Tissue 0.2 31
Bones and Joints 0.1 20
Age 9 All Sites 2.1 429
Brain and ONSd 0.8 173
Leukemia 0.5 98
Acute Lymphocytic Leukemia 0.3 54
Other Endocrine 0.2 41
Soft Tissue 0.2 35
Bones and Joints 0.1 31
Age 10 All Sites 1.9 402
Brain and ONSd 0.8 156
Leukemia 0.5 100
Acute Lymphocytic Leukemia 0.2 51
Bones and Joints 0.2 36
Other Endocrine 0.2 34
Soft Tissue 0.1 28
Age 11 All Sites 1.8 363
Brain and ONSd 0.6 123
Leukemia 0.5 99
Acute Lymphocytic Leukemia 0.2 47
Bones and Joints 0.2 42
Soft Tissue 0.2 32
Other Endocrine 0.1 20
Age 12 All Sites 2.1 434
Brain and ONSd 0.7 140
Leukemia 0.6 127
Acute Lymphocytic Leukemia 0.3 61
Bones and Joints 0.2 49
Soft Tissue 0.1 23
Other Endocrine 0.1 22
Age 13 All Sites 2.1 441
Brain and ONSd 0.6 122
Leukemia 0.5 106
Acute Lymphocytic Leukemia 0.2 49
Bones and Joints 0.3 71
Soft Tissue 0.2 37
Non-Hodgkin Lymphoma 0.1 23
Age 14 All Sites 2.5 520
Leukemia 0.7 136
Acute Lymphocytic Leukemia 0.3 56
Brain and ONSd 0.6 134
Bones and Joints 0.4 87
Soft Tissue 0.3 60
Non-Hodgkin Lymphoma 0.1 24
Age 15 All Sites 2.6 535
Leukemia 0.7 148
Acute Lymphocytic Leukemia 0.3 70
Bones and Joints 0.5 112
Brain and ONSd 0.5 112
Soft Tissue 0.2 51
Non-Hodgkin Lymphoma 0.1 21
Age 16 All Sites 2.6 546
Leukemia 0.7 141
Acute Lymphocytic Leukemia 0.2 51
Brain and ONSd 0.6 123
Bones and Joints 0.5 101
Soft Tissue 0.3 53
Non-Hodgkin Lymphoma 0.1 28
Age 17 All Sites 2.9 609
Leukemia 0.7 154
Acute Lymphocytic Leukemia 0.3 63
Brain and ONSd 0.6 116
Bones and Joints 0.5 103
Soft Tissue 0.4 75
Non-Hodgkin Lymphoma 0.1 23
Age 18 All Sites 2.9 618
Leukemia 0.7 153
Acute Lymphocytic Leukemia 0.3 62
Bones and Joints 0.6 119
Brain and ONSd 0.5 113
Soft Tissue 0.3 71
Non-Hodgkin Lymphoma 0.2 41
Age 19 All Sites 3.1 670
Leukemia 0.8 163
Acute Lymphocytic Leukemia 0.3 67
Bones and Joints 0.5 104
Brain and ONSd 0.5 100
Soft Tissue 0.3 74
Non-Hodgkin Lymphoma 0.2 39

Footnotes:

a Rates are per 100,000 per year. Deaths are for the entire United States over the time period 2013-2017.

b Top 5 cancer sites were determined based on the 2013-2017 age-specific rate.

c US Mortality Files, National Center for Health Statistics, Centers for Disease Control and Prevention.

d ONS = Other Nervous System. IBD = Intrahepatic Bile Duct.

e The rates for sex-specific cancer sites are calculated using the population for both sexes combined.

- Statistic not shown. Rate based on less than 16 cases for the time interval.

Page Navigation: << Previous Next >>


The information on this page is archived and provided for reference purposes only. Persons with disabilities having difficulty accessing information on this page may e-mail for assistance.